Pharmaceuticals

FDA Approves Verona’s Otovile for Maintenance Treatment of Chronic Obstructive Pulmonary Disease

bexib
By bexib 0 Min Read

OTOVIRE is the first inhaled medication approved in 20 years with a new mechanism of action for chronic obstructive pulmonary disease.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article How To Start an LLC in Tennessee (2024)
Next Article Halstead appointed president of Canadian Grains Council – RealAgriculture
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Inside Varo Bank’s GEN AI Copilot build
Banking
Nvidia uses AI to make AI chips
Banking
China commission recommends termination of Beijing’s PNTR status
Manufacturing
Financial institution budgets for next-generation MFA solutions in 2025
Banking